Oral SARS-CoV-2 host responses predict the early COVID-19 disease course

被引:0
|
作者
Seaman, William T. [1 ,2 ]
Keener, Olive [2 ,3 ]
Nanayakkara, Dinelka [4 ]
Mollan, Katie R. [5 ,6 ]
Premkumar, Lakshmanane [7 ]
Cuadra, Edwing Centeno [7 ]
Jones, Corbin D. [5 ,8 ]
Pettifor, Audrey [5 ,6 ]
Bowman, Natalie M. [5 ]
Wang, Frank [9 ]
Webster-Cyriaque, Jennifer [1 ,2 ,5 ,10 ]
机构
[1] Natl Inst Allergy & Infect Dis, NIH, Bethesda, MD 20892 USA
[2] Univ N Carolina, Div Oral & Craniofacial Hlth Sci, Chapel Hill, NC 27599 USA
[3] North Carolina Sch Math & Sci, Durham, NC USA
[4] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA
[5] Univ N Carolina, UNC Sch Med, 111 Mason Farm Rd,Med Biomol Res Bldg,Room 2341b, Chapel Hill, NC 27599 USA
[6] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA
[7] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA
[8] Univ N Carolina, Dept Biol, Chapel Hill, NC USA
[9] Biomedomics Inc, Morrisville, NC USA
[10] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
基金
美国国家卫生研究院;
关键词
D O I
10.1038/s41598-024-67504-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Oral fluids provide ready detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and host responses. This study sought to evaluate relationships between oral virus, oral and systemic anti-SARS-CoV-2-specific antibodies, and symptoms. Oral fluids (saliva/throat wash (saliva/TW)) and serum were collected from asymptomatic and symptomatic, nasopharyngeal (NP) SARS-CoV-2 RT-qPCR+ human participants (n = 45). SARS-CoV-2 RT-qPCR and N-antigen detection by immunoblot and lateral flow assay (LFA) were performed. RT-qPCR for subgenomic RNA (sgRNA) was sequence confirmed. SARS-CoV-2-anti-S protein RBD LFA and ELISA assessed IgM and IgG responses. Structural analysis identified host salivary molecules analogous to SARS-CoV-2-N-antigen. At time of enrollment (baseline, BL), LFA-detected N-antigen in 86% of TW and was immunoblot-confirmed. However, only 3/17 were saliva/TW qPCR+ . Sixty percent of saliva and 83% of TW demonstrated persistent N-antigen at 4 weeks. N-antigen LFA signal in three anti-spike sero-negative participants suggested potential cross-detection of 4 structurally analogous salivary RNA binding proteins (alignment 19-29aa, RMSD 1-1.5 Angstroms). At enrollment, symptomatic participants demonstrated replication-associated sgRNA junctions, were IgG+ (94%/100% in saliva/TW), and IgM+ (63%/54%). At 4 weeks, SARS-CoV-2 IgG (100%/83%) and IgM (80%/67%) persisted. Oral and serum IgG correlated 100% with NP+ PCR status. Cough and fatigue severity (p = 0.010 and 0.018 respectively), and presence of weakness, nausea, and composite upper respiratory symptoms (p = 0.037, 0.005, and 0.017, respectively) were negatively associated with saliva IgM but not TW or serum IgM. Throat wash IgM levels were higher in women compared to men, although the association did not reach statistical significance (median: 290 (female) versus 0.697, p = 0.056). Important to transmission and disease course, oral viral replication and persistence showed clear relationships with select symptoms and early oral IgM responses during early infection. N-antigen cross-reactivity may reflect mimicry of structurally analogous host proteins.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] SARS-CoV-2 and the pandemic of COVID-19
    Adil, Md Tanveer
    Rahman, Rumana
    Whitelaw, Douglas
    Jain, Vigyan
    Al-Taan, Omer
    Rashid, Farhan
    Munasinghe, Aruna
    Jambulingam, Periyathambi
    POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1144) : 110 - 116
  • [22] Coronavirus, COVID-19 and SARS-CoV-2
    Megias, Jorge
    REVISTA HISPANOAMERICANA DE HERNIA, 2020, 8 (02) : 111 - 111
  • [23] Characteristics of SARS-CoV-2 and COVID-19
    Ben Hu
    Hua Guo
    Peng Zhou
    Zheng-Li Shi
    Nature Reviews Microbiology, 2021, 19 : 141 - 154
  • [24] Dementia and SARS-Cov-2/COVID-19
    Zieschang, T.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2021, 54 (SUPPL 1): : S14 - S14
  • [25] SARS-CoV-2 (COVID-19) by the numbers
    Bar-On, Yinon M.
    Flamholz, Avi
    Phillips, Rob
    Milo, Ron
    ELIFE, 2020, 9
  • [26] SARS-CoV-2, COVID-19, and the Eye
    Cunningham, Emmett T.
    Zierhut, Manfred
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (04) : 629 - 630
  • [27] Delirium and SARS-CoV-2/COVID-19
    von Arnim, C.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2021, 54 (SUPPL 1): : S14 - S14
  • [28] Characteristics of SARS-CoV-2 and COVID-19
    Hu, Ben
    Guo, Hua
    Zhou, Peng
    Shi, Zheng-Li
    NATURE REVIEWS MICROBIOLOGY, 2021, 19 (03) : 141 - 154
  • [29] SARS-CoV-2, COVID-19 and Neurodegeneration
    Toenges, Lars
    Klebe, Stephan
    BRAIN SCIENCES, 2022, 12 (07)
  • [30] SARS-CoV-2 and COVID-19 for the ophthalmologist
    Brandao-de-Resende, Camilo
    Diniz-Filho, Alberto
    de Almeida Brito, Fabiano
    Vasconcelos-Santos, Daniel Vitor
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 49 (01): : 70 - 80